ABBV CIK: 1551152

AbbVie Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
22.8
FY22:
24.9
FY23:
22.8
FY24:
18.8
FY25:
19.0
Change from FY21 to FY25
billions USD
FY21:
−2.34
FY22:
−0.62
FY23:
−2.01
FY24:
−20.8
FY25:
−6.64
Change from FY21 to FY25
billions USD
FY21:
−19.0
FY22:
−24.8
FY23:
−17.2
FY24:
−5.21
FY25:
−12.7
billions USD
FY21:
1.30
FY22:
−0.55
FY23:
3.61
FY24:
−7.29
FY25:
−0.30
(positive)
Change from FY21 to FY25
billions USD
FY21:
22.0
FY22:
24.2
FY23:
22.1
FY24:
17.8
FY25:
17.8

All amounts in billions USD Data source:SEC EDGAR